Tom Cecil is Clinical Director at the Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals NHS Foundation Trust and Honorary Transplant Surgeon, Oxford University Hospitals, Oxford, UK.

John Bunni is a Consultant Colorectal and General Surgeon, Royal United Hospital, Bath, UK. He is also Visiting Lecturer, University of Bath, UK; Honorary Lecturer, Cardiff University, UK and was awarded the ASGBI Gold Medal.

Akash Mehta is Consultant Colorectal Surgeon at St Mark's Hospital & Academic Institute, London, UK and holds the ESSO European Certification in Peritoneal Surface Oncology.

SET: UNDERSTANDING AND ASSESSMENT OF PERITONEAL DISEASE. Appendix tumours and pseudomyxoma peritonei: A 'paradigm' for peritoneal disease. Colorectal peritoneal metastases. Peritoneal mesothelioma. Miscellaneous peritoneal malignancies. Quantitative assessment of peritoneal disease. Imaging in peritoneal malignancy. DIALOGUE: INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY. Intraperitoneal chemotherapy. Perioperative and anaesthetic care. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Postoperative care. Postoperative complications. CLOSURE: ONGOING CARE AND FUTURE MANAGEMENT OPTIONS. Histopathological aspects of peritoneal malignancy. Follow-up protocols in peritoneal malignancy. Recurrence of pseudomyxoma peritonei. Future perspectives in peritoneal malignancy.